CHRISTOPHER ELLIOTT: Open Payments
NPI 1700655214 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,049 in 46 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $454 · 2025 $1,049
Food & beverage: $1,049
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $195 |
| Vanda Pharmaceuticals Inc. | 7 | $159 |
| ABBVIE INC. | 5 | $106 |
| Janssen Pharmaceuticals, Inc | 4 | $106 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| Bausch Health US, LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
Products named: ARISTADA, FANAPT, VRAYLAR, Auvelity, CAPLYTA, INVEGA SUSTENNA, Jornay PM, Qelbree.
Industry payments across FL — which companies pay providers there.
